NS · Healthcare

Sai Parenterals Ltd (SAIPARENT)

Pharmaceuticals & Biotechnology

Sai Parenterals Ltd (SAIPARENT) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $26.60B, P/E ratio is 158.42. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SAIPARENT

Market cap

$26.60B

P/E ratio

158.42

Sai Parenterals Ltd (SAIPARENT) — FAQ

What is Sai Parenterals Ltd's market cap?

Sai Parenterals Ltd (SAIPARENT) has a reported market cap of $26.60B (data as of 2026-07-10).

What is SAIPARENT's P/E ratio?

The price-to-earnings (P/E) ratio for Sai Parenterals Ltd (SAIPARENT) is 158.42 (data as of 2026-07-10).

Does Sai Parenterals Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Sai Parenterals Ltd (SAIPARENT). Check the MyAverix Finance app for the latest dividend data.

What sector is Sai Parenterals Ltd in?

Sai Parenterals Ltd (SAIPARENT) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is SAIPARENT listed on?

SAIPARENT is listed on NS.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)